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Rationale: Because the characteristics of all body fluids depends on patient’s health status, is it possible that disadvantaged and 
socially vulnerable mothers may have lower amounts of iron in their breast milk, and that their babies receive lower content of the 
mineral for their normal growth and development. Assuring a preventive treatment of the mother might solve this problem. 
Objective: to demonstrate breast milk iron content from disadvantaged mothers and impact of personalized iron supplementation 
program.  
Materials and Methods: cross-sectional study. Breast milk samples were obtained for ferritin analysis. Health’s services usually 
provides free folic acid and iron treatment however, treatment compliance is low. Patients were random in two groups: “A: Controls” 
that had free iron tablets available from Health Centre; and “B: Intervention” group where patients accepted to be periodically 
contacted at home by health’s team for personalized iron dispensation.  
Results: 360 patients were included. Profilaxis and treatment compliance were 100% and 97,6% for B group while for “Control” one 
was 63% and 34%(p0.0001). Higher breast milk iron levels were detected in Intervention’s mothers compared with control’s patients 
(p0.007). 
Conclusion: Personalized iron prophylaxis and treatment increased breast milk iron levels. Public health policy must ensure iron 
dispensation for each underserved mother in order to reduce children problems associate to iron deficiency during the first year of 
their life.  
 
Keywords: breastfeeding; iron deficiency; health; policy 
Introduction 
Iron deficiency is one of the major health 
problems among children less than 1 year old [1].  
Maternal anaemia leads to anaemia in newborn infants 
[2]. Unfortunately, iron deficiency and anaemia are 
prevalent in many countries of South America, associated 
to the socio-economical situation [3].     
Iron deficiency can have deleterious effects on 
behaviour [4-7], immune system [8-13], and mental [5] 
and physical [14] development. Prevention of anaemia in 
newborns should therefore be a priority for public health 
policies. 
Although substantial prevalence rates among 
disadvantaged children have been reported [4], official 
programs attempted to correct this iron deficiency 
anaemia by delivering iron-fortified milk and other dietary 
supplements available free of charge to the 
underprivileged population in many countries [5]. 
However, this point is controversial since even if 
official policies enhance the breastfeeding during the first 
6 months of life of newborns [15], the quality of that breast 
milk will depend on the mother’s health and nutrition.  
We started the present study, in order to 
demonstrate the iron content of breast milk from mothers 
belonging to disadvantaged families and the impact of a 
personalized program for iron suplementation on those 
mothers.  
Methods 
Type of Study and Population sample 
This is a cross-sectional study consisting of two 
phases (descriptive and analytical) with a quantitative 
approach. This study was conducted in the capital of 
Buenos Aires province (La Plata) which, according to the 
National Institute of Statistics and Census (INDEC) (2001 
census) is a faithful exponent of most Argentinian urban 
cities [16].  Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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Breast milk samples were obtained from 
pregnant women belonging to disadvantaged families 
defined by the household income, geographical proximity 
of the house surveyed to a local health center (LHC) and 
by the Unsatisfed Basic Needs (UBN) index [17], which is 
an index composed of socio-economic indicators 
incorporating like house overcrowding (three or more 
family members per room); lack of sewerage services; 
unstable house construction; illiteracy in at least one 
member of that family; or children in the house who is not 
attending school.  
The sample size was calculated according to 
routine control theory, with a confidence of 95% (alpha 
error = 5%) and an accuracy of 5% in a theoretical 
minimum of 124 dwellings, using the following formula: 
 
                  N • Z2 • p (1-p)  
n =     .                                          . 
             d2 • (N-1) + Z2 • p (1-p)  
 
where  n  is  the  sample  size, N  the  total  population, Z 
the value of z for confidence level (1 - alpha), p the 
expected proportion of iron deficiency in the population 
and d  the absolute accuracy.  
The unit of analysis was the “pregnant women”. 
The criteria for including participants in the study were: 
age (mothers who at the time of the survey were 16 years 
or older); pregnant women coming from the geographical 
area selected for the study or that lived in the region for 
over a year; and that voluntary accepted to participate in 
the study (consent agreement).   
Before milk sample collection, a second inclusion 
criteria was applied to all mothers previously included in 
the study. These criteria were: 1) gestational age  37 
weeks, 2) birth weight > 2500 grams 3) infant exclusively 
breastfed at 2 months. 
 
Groups of Study 
For all pregnant women, folic acid (5 mg folate 
pill/day) and iron (200mg pill of ferrous sulphate once or 
twice day) treatment was available. However, sample was 
random divided into two groups:  Group A received free 
medicines from the Health Center near their homes; 
Group B accepted to be contacted monthly by a member 
of the Health team in order to personalized free iron 
dispense for prophylaxis or treatment during all pregnancy 
period until 45 days after the delivery. This medicine was 
always dispensed by that same health professional either 
through the health center, or in case that patient did not 
attend his periodical consultation, drugs were dispensed 
at the patient’s home.  
 
Milk sampling and laboratory assay 
For sample collection, mothers were instructed to 
ﬁrst clean their breasts with a sterile disposable towel 
soaked with water, then allowing the area to air dry. 
Breast-milk samples were collected at 2nd month 
postpartum. Samples were collected during the morning 
after 2 hours after the previous breastfeeding. Milk 
expression was done from only one breast, between from 
9:00 am to 11:00 am under supervision of her Obstetric. 
All mothers received explicit instructions regarding the 
handling of a glass jar. After discarding an initial 4 mL of 
milk, an aliquot of 10 ml was collected by manual plastic 
disposable pump into clean sterile tested plastic jars 
containers provided by the National University of La Plata 
(UNLP) and transferred to iron-free polyethylene tubes. 
Milk samples were preserved at 4°C until they were 
analyzed for iron content by absorption 
spectrophotometry. None of the mothers had mastitis or 
febrile illness during the period of study.  
Samples were ﬁnally transferred to screw-cap, 
plastic tubes and frozen at -20 °C until analysis. For 
laboratory iron analysis, samples were thawed, mixed 
thoroughly, and processed with a trienzyme digestion 
procedure before microbiological assay at room 
temperature and then at subboiling temperature for 6–9 h. 
Iron concentration was determined by absorption 
spectrometry. The analyzed reference values were within 
95–105% of the certified value. 
 
Statistical analysis 
Student’s t test was used for variables analysis 
with was performed by using statistical software SPSS 10. 
Statistical significance was set at P < 0.05. All values in 
the text are expressed as means ± SDs.  
Results 
Three hundred and sixty patients were included 
in the study. 174 of them were included in group A 
(control) and 186 patients were followed up in a 
personalized iron treatment (group B – intervention).  
Both study groups (A control, B intervention) 
were comparable in maternal age, maternal median 
serum hemoglobin level, gestational age and new born 




Table 1. Patient’s features 
 
Parameter  Group A 
(control n=174) 
Group B 




maternal age  
(minutes) 
26,93 7.41  27,43 6.07  NS 
median serum hemoglobin level (gr/dl)  11,41  1,02  11,79  1,42  NS 
gestational age  
(weeks) 
394.5  397.2  NS 
newborn weight  3301574  3309611  NS 
time to cut the umbilical cord (minutes)  3.92.1  3.71.8  NS 
NS: non significant 
 
Free iron tablets (each tablet: 200 mg of iron 
sulphate -60mg of elemental iron-) and folic acid tablets 
(each tablet: 1 mg of folate) were available all time in 
health centres (HC).  
Any health team member could give free 
iron/folate prophylaxis or treatment to the patients, either 
if they demanded so (group A –“control group”) or if 
patients received medicines in a personalized dispensed 
way by their responsible person in health centre or at 
home (group B).  In this last case, Public health service 
labelled the medicines containers with each patient’s 
name and last name.  
Iron and Folate prophylaxis was given to a 100% 
of mothers belonging to Intervention group (group B) 
while in anaemia’s patients, treatment compliance was 
97,6% for the same group.  For Control Group “A”, 
prophylaxis and treatment compliance were 63% and 
34% respectively (statistical differences between A and B 
groups were p 0.003 and 0.0001 for prophylaxis and 
treatment respectively).  
Comparing control’s mothers (group A), with 
mothers that received personalized treatment during their 
pregnancy (group B) it was observed that the last group 





Table 2.   Iron levels in anaemic patients during their last trimester of pregnancy 
 





Iron milk levels (mg/L)  0.29  0.18  0.41 0.15  0.007 
Controls patients ; ** Intervention group 
 
Table 3.  Breast milk iron levels  
Parameter  Group A 
(control n=174) 
Group B 
(personalized  medicine 
dispense n=186) 
P value 
Iron milk levels (mg/L)  0.32  0.14  0.48 0.17  < 0.001 
 
 
Even in mothers who had anaemia during their 
last trimester of pregnancy, personalized regular iron 
dispense, assured higher breast milk iron levels than the 
ones of the control group.   
Discussion 
Iron deficiency is frequent in children under 1 
year old in many developing countries like Argentina. 
Assuring iron prophilaxis and treatment to mothers during 
the pregnancy period may reduce this health problem.  
Especially in Argentina, the access to iron 
treatment is guaranteed by the Ministry of Health, by 
REMEDIAR program, which provides the Health Centres 
enough iron for all population. However, although 
medicine is available, treatment is still not assured since 
patients must have access to health centres to obtain the 
treatment.  
We have previously demonstrated this situation 
[18], providing a medicine is not enough; an alternative 
strategy to obtain better treatment compliance is then 
needed.  
Personalized attention might improve health care 
performance as our group has shown previously [19].   
It is well known that severe anaemia, present in 
the early gestation period, along with concomitant 
maternal malnutrition, may be associated with anaemia in 
newborns.  Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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Nowadays, because of the convenience of 
mothers, commercial’s milk formulations have been used 
(and abused) to feed their newborns. However, official 
recommendations are in favor of maintaining exclusive 
breastfeeding until six months of life, as it does clearly 
provide immunological benefits for the children. 
It is therefore extremely important to ensure the 
best possible quality and highest iron content as possible 
of breast milk. 
The present study demonstrated that iron 
content in breast milk is impaired when mothers have 
iron-deﬁciency during the pregnancy period. Even if 
mothers had anaemia during pregnancy, our data shows 
that a program that assures a personalized iron treatment, 
improves breast milk iron content. 
An official program that guarantees iron 
prophylaxis and treatment to pregnant women will 
increase breast milk iron levels reducing children 
problems associate to iron deficiency during the first year 
of their life.  
The authors have no conflict of interest to 
declare about this paper. All the funds for this study were 
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